Host- and disease-specific factors affecting steatosis in chronic hepatitis C.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Hepatology

• Publication date

  1998-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0016-5085(98)84989-5PMID 9722200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

  1998cited by this paper
• Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

  1997cited by this paper
• Nonalcoholic steatohepatitis.

  1997cited by this paper
• Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

  1997cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.

  1997cited by this paper
• Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis

  1997cited by this paper
• Histological findings in chronic hepatitis C with autoimmune features

  1997cited by this paper
• Case Report: Chronic Hepatitis C and Autoimmunity (Good Response to Immunosuppressive Treatment)

  1997cited by this paper
• Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

  1996cited by this paper
• Obesity in the Caribbean.

  1996cited by this paper
• Liver steatosis and chronic hepatitis C: a spurious association?

  1996cited by this paper
• Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C

  1996cited by this paper
• Histopathologic findings in chronic hepatitis C.

  1996cited by this paper
• Evidence that the HLA DQA1*03 allele confers protection from chronic HCV‐infection in Northern European Caucasoids

  1996cited by this paper
• Prevalence of obesity.

  1996cited by this paper
• The genetics of obesity.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis.

  1995cited by this paper
• Histopathology of Hepatitis C Virus Infection

  1995cited by this paper
• Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C.

  1994cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1994cited by this paper
• Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection.

  1994cited by this paper
• Eradication of Hepatitis C Virus RNA after Alpha-Interferon Therapy

  1994cited by this paper
• HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

  1994cited by this paper
• Classification of chronic hepatitis: Diagnosis, grading and staging

  1994cited by this paper
• The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study

  1993cited by this paper
• Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.

  1993cited by this paper
• Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

  1993cited by this paper
• Genetic predispositions for the immunological features of chronic active hepatitis

  1993cited by this paper
• Histological patterns of prolonged hepatitis C infection.

  1993cited by this paper
• The clinical associations with hepatic steatosis: a retrospective study.

  1992cited by this paper
• The pathology of hepatitis C

  1992cited by this paper
• The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis

  1992cited by this paper
• Immunohistochemical detection of hepatitis C virus–infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome

  1992cited by this paper
• Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis.

  1992cited by this paper
• Obesity and hepatotoxins as risk factors for fatty liver disease.

  1991cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• Inheritance of the amount and distribution of human body fat.

  1988cited by this paper
• Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.

  1987cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981cited by this paper

• Hepatic steatosis estimated by VCTE-derived CAP scores was associated with lower risks of liver-related events and all-cause mortality in patients with chronic liver disease.

  2024cites this paper
• Induction of phospholipase A2 group 4C by HCV infection regulates lipid droplet formation

  2024cites this paper
• Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight

  2023cites this paper
• The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments

  2021cites this paper
• Association of Adiponutrin/Patatin Like Phospholipase 3 (PNPLA3) I148M Gene Variant with Chronic Hepatitis C in Egyptian Children

  2021cites this paper
• Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C

  2021cites this paper
• Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond

  2021cites this paper
• The hepatic lipidome: From basic science to clinical translation.

  2020cites this paper
• Review article: iron disturbances in chronic liver diseases other than haemochromatosis – pathogenic, prognostic, and therapeutic implications

  2019cites this paper
• Paediatric fatty liver disease (PeFLD): All is not NAFLD - Pathophysiological insights and approach to management.

  2018cites this paper
• Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis

  2018cites this paper
• Anti‐adipogenic and antiviral effects of l‐carnitine on hepatitis C virus infection

  2017cites this paper
• The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis

  2017cites this paper
• Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C

  2017cites this paper
• Mechanisms of intrahepatic triglyceride accumulation.

  2016cites this paper
• Hepatitis C Virus, Insulin Resistance, and Steatosis

  2016cites this paper
• Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease.

  2016cites this paper
• NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations

  2016cites this paper
• Serum Gamma-Glutamyl Transferase “ GGT ” Level as an Indicator of Liver Histopathology in Chronic Hepatitis C Patients

  2016cites this paper
• Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C

  2016cites this paper
• Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

  2016cites this paper
• Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients

  2015cites this paper
• Lipid Profile and Hepatic Steatosis in Hepatitis C Infected Egyptian Survivors of Childhood Cancer

  2015cites this paper
• Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.

  2015cites this paper
• Insulin resistance and its consequences in chronic hepatitis C

  2015cites this paper
• PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

  2015cites this paper
• Hepatitis C virus infection, metabolic disorders and non-alcoholic fatty liver disease: a literature review.

  2015cites this paper
• Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection.

  2015cites this paper
• FREQUENCY AND SEVERITY OF STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C.

  2015cites this paper
• Stearoyl Coenzyme A Desaturase 1 Is Associated with Hepatitis C Virus Replication Complex and Regulates Viral Replication

  2014cites this paper
• Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production.

  2014cites this paper
• Polymorphisms in methylenetetrahydrofolate reductase gene: Their impact on liver steatosis and fibrosis of chronic hepatitis c patients

  2014cites this paper
• Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

  2014cites this paper
• Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.

  2014cites this paper
• The impact of obesity and metabolic syndrome on chronic hepatitis C.

  2014cites this paper
• Hepatitis C recurrence: the Achilles heel of liver transplantation

  2014cites this paper
• The incidence rate of hepatosteatose in virus carriers with inactive Hepatitis B

  2014cites this paper
• Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction

  2013cites this paper
• Chronic Hepatitis C among Immigrants Living in Canada: Natural History, Disease Burden, and Cost-effectiveness of Screening

  2013cites this paper
• Nonalcoholic fatty liver disease following liver transplantation

  2013cites this paper
• PNPLA3 I148M polymorphism and progressive liver disease.

  2013cites this paper
• The strange and critical intersection of hepatitis C and lipoprotein metabolism: “C‐zing” the oil

  2013cites this paper
• Lipids and HCV

  2012cites this paper
• Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studies

  2012cites this paper
• Hepatic steatosis in HCV infection genotype 4 in Egypt

  2012cites this paper
• [Hepatitis C virus genotype 3: that simple, yet that complex (corrected)].

  2012cites this paper
• The interaction of metabolic factors with HCV infection: does it matter?

  2012cites this paper
• Autophagy protects cells from HCV-induced defects in lipid metabolism.

  2012cites this paper
• Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.

  2012cites this paper
• Insulin Resistance, Steatosis, and Fibrosis in Egyptian Patients with Chronic Hepatitis C Virus Infection

  2011cites this paper
• Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis

  2011cites this paper
• Drug-Induced Autoimmune-Like Hepatitis

  2011cites this paper
• Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

  2011cites this paper
• Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B.

  2011cites this paper
• Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.

  2011cites this paper
• Alteration of hepatic nuclear receptor‐mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking

  2011cites this paper
• Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults

  2011cites this paper
• Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

  2011cites this paper
• Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.

  2011cites this paper
• Impact of HCV genetic differences on pathobiology of disease

  2011cites this paper
• Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma.

  2011cites this paper
• Predictors of Sustained Virologic Response (SVR) of Chronic Hepatitis C

  2011cites this paper
• Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis.

  2011cites this paper
• Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.

  2011cites this paper
• Association between liver steatosis and angiogenesis in chronic hepatitis C.

  2011cites this paper
• HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners

  2011cites this paper
• Effect of Liver Steatosis on Therapeutic Response in Chronic Hepatitis C Virus Genotype 1 Infected Patients in Hungary

  2010cites this paper
• Relationship between the production of autoantibodies to oxidized low-density lipoprotein and hepatic steatosis in patients with chronic hepatitis C

  2010cites this paper
• Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology.

  2010cites this paper
• Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community

  2010cites this paper
• Liver cell steatosis in hepatitis C infected patients

  2010cites this paper
• Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.

  2010cites this paper
• The importance of steatosis in chronic hepatitis C infection and its management: A review

  2010cites this paper
• Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)

  2010cites this paper
• Abnormalities of lipid metabolism in hepatitis C virus infection

  2010cites this paper
• Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.

  2009cites this paper
• Insulin resistance and steatosis in chronic hepatitis C.

  2009cites this paper
• Microsomal triglyceride transfer protein polymorphism (−493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C

  2009cites this paper
• Liver fibrosis and therapeutic strategies: the goal for improving metabolism.

  2009cites this paper
• Characterization of incidentally detected asymptomatic hepatitis B positive subjects in Egypt

  2009cites this paper
• Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity; a 5‐year prospective follow‐up study variation of insulin sensitivity in HCV patients

  2009cites this paper
• Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors

  2009cites this paper
• Hepatitis C virus and glucose and lipid metabolism

  2009cites this paper
• Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C

  2009cites this paper
• l-Carnitine Treatment Reduces Steatosis in Patients with Chronic Hepatitis C Treated with α-Interferon and Ribavirin

  2008cites this paper
• Hepatitis C virus and glucose and lipid metabolism.

  2008cites this paper
• Hepatitis B and fatty liver: Causal or coincidental?

  2008cites this paper
• Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors

  2008cites this paper
• Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy.

  2008cites this paper
• Treatment predictors of a sustained virologic response in hepatitis B and C.

  2008cites this paper
• Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis

  2008cites this paper
• Genotype‐specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C

  2008cites this paper
• The Accuracy of Sonography in Predicting Steatosis and Fibrosis in Chronic Hepatitis C

  2008cites this paper
• Increased prevalence of type II diabetes mellitus in hepatitis C virus infection in western India.

  2008cites this paper
• Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic.

  2008cites this paper
• Doença hepática não-alcoólica gordurosa e risco de cirrose Nonalcoholic fatty liver disease and risk of cirrhosis

  2008cites this paper
• Hepatitis C and steatosis.

  2007cites this paper
• Increased liver mast cell recruitment in patients with chronic C virus‐related hepatitis and histologically documented steatosis

  2007cites this paper
• Hepatitis C virus: the viral way to fatty liver.

  2007cites this paper
• Race, insulin resistance and hepatic steatosis in chronic hepatitis C

  2007cites this paper